LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)

NCT03946527 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Paraganglioma
Pheochromocytoma

Interventions

DRUG: Lanreotide

Sponsor

Antonio Fojo

Collaborators

[object Object]